Dr. Peter Chang, MD

Dr. Chang practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Chang's NPI, 1275733867, was assigned on July 20, 2007. Dr. Chang graduated from Weill Cornell Medicine in 2007. Dr. Chang holds Massachusetts license 231628.

Dr. Chang's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Chang's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Chang is also affiliated with Brigham and Women's Hospital. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Chang to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chang is board certified in urology by the American Board of Urology. Dr. Chang is licensed in Massachusetts.

Dmand AI lists bladder removal, enlarged prostate, kidney cysts, kidney removal surgery, kidney stones, prostate cancer, prostate inflammation or infection and prostate surgery among the conditions Dr. Chang treats.

CMS data shows 586 Medicare services from Dr. Chang across 11 procedure codes in 2024, for 413 Medicare patients. Medicare paid $87,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 413 Medicare patients who saw Dr. Chang in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 72% have cancer. 14% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 70, with 26% women.

In 2024, Dr. Chang wrote 405 Medicare Part D claims for 129 patients. 99% of them were for generic drugs. CMS names the drug for 337 of them, across 5 drugs with 11 or more claims each, at $5,159 in total drug cost. In 2023, CMS named 301 claims across 5 drugs.

Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth. CMS counts 39 procedures of prostate resection by Dr. Chang, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Chang, published from 2014 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Urinary Bladder Neoplasms. Dr. Chang has published most often in Urol Oncol. Dr. Chang's most frequent co-authors are Boris Gershman, MD, Ruslan Korets, MD and Aria F. Olumi, FACS, MD.

Dmand AI links Dr. Chang to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 47 general payments to Dr. Chang from 12 drug and device companies from 2016 to 2024. Education make up the largest share, 63% of the total. Intuitive Surgical, Inc. paid the most, $17,532.

Dr. Chang graduated from Weill Cornell Medicine in 2007.

Dr. Chang is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.